Volume 19, Issue 75 (4-2011)                   J Adv Med Biomed Res 2011, 19(75): 11-17 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hosseini S H, Amoghli Tabrizi B, Mazlom Mogaddam S S R. Evaluation at Ginseng on Lipid Profiles, Liver and Renal Markers in Diabetic Rats. J Adv Med Biomed Res 2011; 19 (75) :11-17
URL: http://journal.zums.ac.ir/article-1-1487-en.html
1- Dept. of Pharmacology, Tehran Sciences and Research Branch, Islamic Azad University, Tehran, Iran , dr.h.hoseini@gmail.com
2- Islamic Azad University, Tabriz Branch, Tabriz, Iran
3- Private Office, Meshhad, Iran
Abstract:   (182088 Views)

Background and Objective: Diabetes is a metabolic disorder that occurs as a consequence of decrease in insulin secretion or resistance to insulin. Most diabetes related treatments have problems with adverse reactions. Natural therapeutics have been in use from long time ago up to present time. Ginseng is a traditional drug used for treatment of many dieses particularly diabetes. The aim of this study was to find out the effect of oral Ginseng on the serum glucose and other biochemical parameters such as lipid profile.
Materials and Methods: In this study 30 male rats with a body weight of 250±25 gr and age of 4-6 months was used. Each animal was housed under controlled temperature (21+_2 C) and standard conditions with free access to food and water. Blood test was carried out to measure glucoses and other biochemical parameters such as cholesterol, TG, ALT, AST and BUN.  Animals were equally divided into three groups; 1-control group, 2-the STZ-induced-diabetes (60 mg/kg) group, 3- the STZ-induced-diabetes (60 mg/kg) and150 mg/kg oral ginseng. The study was lasted for 6 weeks. Blood samples were taken and tested for glucoses and other parameters.
Results: The average blood sugar in the control group was 131.1±7.9 mg/dl, but it was higher than 550mg/dl in streptozocine- received group. In group 3, which received ginseng, blood sugar decreased up to 50%. Cholestrol decreased up to 40% in the treatment group. Among the measured parameters HDL showed a 50%decrease in treatment group in comparison with diabetic group. AST and ALT values between the control and treatment groups did not show a significant difference. BUN values decreased from 71.6±6.6 in diabetic group to 50.1±5.7 mg dl in the treatment group.
Conclusion: The results of this study revealed that ginseng can be considered as a substance which decreases blood glucoses, reduces diabetes adverse reactions, and consequently diminishing blood lipids in animal model. However, to apply these results to human, further studies are needed to be carried out.

Full-Text [PDF 179 kb]   (162433 Downloads)    
Type of Study: Original Research Article |
Received: 2011/06/8 | Accepted: 2014/06/22 | Published: 2014/06/22

References
1. Attel AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes. 2002; 51: 1851-8. [DOI:10.2337/diabetes.51.6.1851] [PMID]
2. Vuksan V, Sievenpiper JL, Xu Z, et al. Konjac -Mannan and American ginseng: emerging alternative therapies for type 2 diabetes mellitus. J Am College Nutr. 2001; 20: 370-80.
3. Lim BV, Sshin MC, Jang MH, et al. Ginseng radix increases cell proliferation in dentate gyrus of rats with streptozotocin - induced diabetes. Biol pharm Bull. 2002; 25: 1550-4. [DOI:10.1248/bpb.25.1550] [PMID]
4. Sievenpiper JL, Arnason JT, Lawrence AL, Vuksan V. Null and opposing effects of asian ginseng (Panax ginseng C.A. meyer) on acute glycemia: results of two acute dose escalation studies. J Am Collge Nutr. 2003; 22: 524-32. [DOI:10.1080/07315724.2003.10719331] [PMID]
5. Rahman A, Zaman K. Medicinal plants with hypoglycemic activity. J Elhani-pharmacol. 1989; 26: 1-5. [DOI:10.1016/0378-8741(89)90112-8]
6. Yoon SH, Han EJ, Sung JH, Chung SH. Anti-diabetic Effects of compound K versus Metformin versus compound K- metformin combination therapy in diabetic db/db mice. Biol Pharm Bull. 2007; 30: 2196- 200. [DOI:10.1248/bpb.30.2196] [PMID]
7. Markuns JF, Napoli R, Hirshman MF, Davalli AM, Cheatham B, Goodyear LJ. Effects of streptozocin - induced diabetes and islat cell transplantation on insulin signaling in rat skeletal muscle. Endocrinol. 1999; 140: 106-11. [DOI:10.1210/endo.140.1.6427] [PMID]
8. Becker KL. Principales and practice of endocrinology and metabolism. Philadelphia: Lippincott. 1990.
9. Craig CR, Stitzel RE. Modern pharmacology Boston: Little Brown and Company.1994.
10. Ito T, Uchikoshi F, Tori M, et al. Immunological characteristics of pancreas transplantation. Review and our experimental experience. Pancreas. 2003; 27: 31-7. [DOI:10.1097/00006676-200307000-00005] [PMID]
11. Kaufman DB, Lowe WLJR. Clinical islet transplantation. Curr Diab Rep. 2003; 3: 344-50. [DOI:10.1007/s11892-003-0028-7] [PMID]
12. Yamaoka T. Regeneration therapy for diabetes mellitus. Expert Opin Biol Ther. 2003; 3: 425-33. [DOI:10.1517/14712598.3.3.425] [PMID]
13. Chong, SKF, Oberholzer VG. Ginseng- is there a use in clinical medicine? Postgrad Med J. 1988; 64: 841-6. [DOI:10.1136/pgmj.64.757.841] [PMID] [PMCID]
14. Xie JT, Mehendale SR, Wang A, et al. American ginseng leaf: ginsenosid analysis and hypoglycemic activity. Pharmacol Res. 2004; 49: 113-7. [DOI:10.1016/j.phrs.2003.07.015] [PMID]
15. Yamanoto M, Uemura T, Nakama S, Uemiya M, Kumagai A. Serum HDL-cholesterol increasing and fatty liver improving actions of Panax ginseing in high cholesterol diet – fed rats with clinical effect on hyperlipidemia in man. Am J Chin Med. 1983; 11: 96-101.

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb